In this study, E2F2 has been shown to play a role in promoting the cell cycle transition from G1 to s and enhancing the proliferation of pancreatic cancer cells. E2F2 has been shown to enhance the chemoresistance of pancreatic cancer cells to gemcitabine by up regulating the expression of RRM2 and its downstream dCK.<br>Key words: pancreatic cancer, gemcitabine E2F2<br>Introduction:<br>Pancreatic cancer is a highly malignant tumor. The five-year survival rate of pancreatic cancer patients is less than 5%, and the death caused by pancreatic cancer ranks the fourth among cancer-related deaths.<br>
正在翻译中..